Multiple Myeloma (Refractory) Medication Savings with TheDrugClub
Discount pricing may be available. Current formulary eligibility is being verified; a condition association does not establish FREE coverage.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
About Multiple Myeloma (Refractory)
Refractory multiple myeloma is a challenging form of blood cancer where the disease has stopped responding to initial treatments, requiring new approaches. Managing this condition involves complex, often high-cost medications. TheDrugClub helps patients access these vital prescriptions at more affordable prices, easing the financial burden during a difficult time.
What is Refractory Multiple Myeloma?
Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell found in the bone marrow. These cancerous plasma cells can crowd out healthy blood cells and produce abnormal proteins, leading to bone damage, kidney problems, weakened immune function, and anemia. When multiple myeloma is "refractory," it means the disease has either not responded to initial treatments (primary refractory) or has returned and no longer responds to treatments that previously worked (relapsed and refractory). This presents significant challenges, as patients need new strategies
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.